Elon Musk’s start-up Neuralink on Thursday said it has approval from US regulators to test its brain implants in people. Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is “an important first step” for its technology, which is intended to let brains interface directly with computers.
You May Also Like
Saudi Company Aramco’s financial value increases putting Apple under pressure
As global energy prices rise, Saudi Aramco is on the verge of…
- Reesha Mirza
- October 7, 2021
COAS, PM Imran briefed on pandemic response
On Monday, Prime Minister Imran Khan and Army Chief, Gen Qamar Javed…
- Alina Hashmi
- October 18, 2021
EU ready to approve drugs against Covid-19
Brussels: On Nov 9, the European Union drugs regulator is all ready…
- Alina Hashmi
- November 9, 2021
Global groups propose pandemic plan
Chicago: On April 5, four organizations focused on global health and the…
- Alina Hashmi
- April 5, 2022